Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 152,927 shares at $55.00 ($8.4M) on 2019-12-10, disclosed to the SEC on 2019-12-11.
Open-market sale of $8.4M DCPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.00 | 30,175 | $1.7M | 19.7% |
| 2 | $55.00 | 28,822 | $1.6M | 18.8% |
| 3 | $55.00 | 93,930 | $5.2M | 61.4% |
| Total | $55.00 avg | 152,927 | $8.4M | 100% |
| Filing → |
| DCPH | SELL | 2023-01-19 | $102K | — | Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2022-02-18 | $12K | — | Filing → |